{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-25-001425","form_type":"8-K","ticker":"PTHS","cik":"0001919246","company_name":"Pelthos Therapeutics Inc.","filed_at":"2025-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.589274+00:00","generated_at":"2026-05-17T08:39:19.458475+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Pelthos Therapeutics to present at Wells Fargo 2025 Healthcare Conference on Sept 3","bullets":["CEO Scott Plesha and CFO Frank Knuettel to present at Wells Fargo Healthcare Conference on Sept 3, 2025 at 1:30 pm ET.","Company to provide pipeline update and discuss commercial launch of ZELSUVMI (berdazimer) for molluscum contagiosum.","Webcast and replay available on company's website for 90 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-25-001425","json":"https://secwatch.observer/filing/0001753926-25-001425.json","markdown":"https://secwatch.observer/filing/0001753926-25-001425.md","text":"https://secwatch.observer/filing/0001753926-25-001425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1919246/000175392625001425/0001753926-25-001425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1919246/000175392625001425/g084940_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:39:19.458475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}